Indefinite-Lived Intangible Assets and Other Long-Term Assets (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Indefinite-lived Intangible Assets [Line Items] | ||
| Asset Impairment Charges | $ (0) | $ 9,243,128 |
| Serum Institute of India Ltd [Member] | ||
| Indefinite-lived Intangible Assets [Line Items] | ||
| Prepaid clinical supply | $ 700,000 | 700,000 |
| OncoHist [Member] | ||
| Indefinite-lived Intangible Assets [Line Items] | ||
| Asset Impairment Charges | $ 9,200,000 | |
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|